Strategies and opportunities for drug development in heart failure

JAMA. 2013 Apr 17;309(15):1593-4. doi: 10.1001/jama.2013.1063.
No abstract available

MeSH terms

  • Biomarkers
  • Clinical Trials as Topic
  • Drug Discovery*
  • Dyspnea / drug therapy
  • Dyspnea / etiology
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Heart Failure / mortality
  • Heart Failure / physiopathology*
  • Hospitalization
  • Humans
  • Population Dynamics
  • Registries
  • Risk
  • Treatment Outcome

Substances

  • Biomarkers